Professor Greg Shaw, the trial lead from UCL Surgery & Interventional Science and Consultant Urologist at UCLH, said: “Our results show that, by using NeuroSAFE, nearly twice as many men don’t have to ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

When a man receives a prostate cancer diagnosis, thoughts often race toward treatment options and survival rates. However, the recovery journey after prostate surgery represents a critical chapter ...

After reviewing hundreds of hours of surgical video, a team led by Cedars-Sinai investigators has created a system that links specific steps performed during a surgical procedure to how well patients ...

A BREAKTHROUGH IN PROSTATE CANCER TREATMENT IS NOW AVAILABLE RIGHT HERE IN CINCINNATI, AND ONE LOCAL HOSPITAL AND DOCTOR ARE UTILIZING IT WITH EARLY SUCCESS. WLWT NEWS FIVE’S MEGAN MITCHELL SPOKE WITH ...

It is an involved procedure that requires expertise, but it isn't expensive, particularly given the benefits it offers for patients, and most importantly doesn't jeopardize cancer control. NeuroSAFE ...

According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...

In a new study led by the UCLA Health Jonsson Comprehensive Cancer Center, investigators show that using advanced MRI imaging and targeted focal therapy can help many men with low- to ...

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...